Supermax BhdSPMXF 51 3-Year RORE % is 40.00 as of Mar. 2026. GuruFocus rates SPMXF with a GF Score™ of 51/100 and a GF Value™ of $0.37. The stock has 6 warning signs investors should review. Among 781 Medical Devices & Instruments companies, Supermax Bhd ranks better than 82.07% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Supermax Bhd's 3-Year RORE % for the quarter that ended in Mar. 2026 was 40.00%.
The industry rank for Supermax Bhd's 3-Year RORE % or its related term are showing as below:
SPMXF's 3-Year RORE % is ranked better than 82.07% of 781
companies
in the Medical Devices & Instruments industry
Industry Median: -4.27
vs SPMXF: 40.00
Supermax Bhd (OTCPK:SPMXF) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Supermax Bhd 3-Year RORE % Related Terms
Supermax Bhd 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Supermax Bhd's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SPMXF vs ISRG, BDX, MDLN: 3-Year RORE % Comparison
For the Medical Instruments & Supplies subindustry, Supermax Bhd's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supermax Bhd 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Supermax Bhd's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Supermax Bhd's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Supermax Bhd (SPMXF) has a 3-Year RORE % of 40.00 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Supermax Bhd and its competitors. According to the industry distribution chart, Supermax Bhd ranks #140 out of 781 companies in the Medical Devices & Instruments industry, placing it in the top 17.9%.
Is Supermax Bhd's 3-Year RORE % too high?
Supermax Bhd's current 3-Year RORE % is 40.00. Based on the distribution chart, Supermax Bhd ranks #140 out of 781 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Supermax Bhd has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's 3-Year RORE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Supermax Bhd ranks #140 out of 781 companies for 3-Year RORE %. This places Supermax Bhd in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Supermax Bhd and its competitors. Supermax Bhd's current 3-Year RORE % is 40.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Supermax Bhd (SPMXF) has a current 3-Year RORE % of 40.00. The stock's GF Value™ is $0.37, compared to a current price of $0.15 — trading 59.5% below its estimated fair value. The current 3-Year RORE % is 40.00. Supermax Bhd's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Supermax Bhd (SPMXF), the current 3-Year RORE % is 40.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supermax Bhd (SPMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued.
The current stock price of $0.15 is trading 59.5% below its estimated GF Value™ of $0.37.
Key valuation signals for SPMXF:
3-Year RORE %: 40.00
GF Value™: $0.37 vs. price of $0.15 (59.5% below fair value)
No single metric tells the full story. See the SPMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
51GF Score
Get the complete analysis for SPMXF
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SPMXF has been successfully added to your 
